Cargando…
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
Major advances in understanding how genetics underlies Parkinson’s disease (PD) have provided new opportunities for understanding disease pathogenesis and potential new targets for therapeutic intervention. One such target is leucine-rich repeat kinase 2 (LRRK2), an enigmatic enzyme implicated in bo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076802/ https://www.ncbi.nlm.nih.gov/pubmed/27799832 http://dx.doi.org/10.2147/CPAA.S102191 |